Department of Gastroenterology, The Affiliated Hospital of Guangdong Medical College, South Peoples Avenue No. 57, Xiashan District, Zhanjiang, Guangdong, China,
Mol Cell Biochem. 2014 Mar;388(1-2):249-59. doi: 10.1007/s11010-013-1916-z. Epub 2013 Dec 17.
MicroRNAs (miRNAs, miRs) play important roles in pathogenesis and development of human diseases, including malignancy. Some may affect tumor progression through targeting tumor suppressor genes. MiR-135b has been shown to be upregulated in CRC. In this study, we evaluated the role of miR-135b in colorectal cancer (CRC) and its regulatory role for metastasis suppressor-1 (MTSS1) and its mechanisms. The levels of miR-135b and MTSS1 gene expression in 35 CRC and corresponding cancer-adjacent tissues, 27 colorectal adenoma, and 16 normal tissue samples were quantified using qRT-PCR and western blot analysis. The effect of miR-135b on MTSS1 expression was assessed by miR-135b mimics or inhibitor transfection to deregulate miR-135b expression. The direct interaction between them was verified by 3'-UTR dual-luciferase reporter assay. Furthermore, the roles of miR-135b in regulating CRC cells migration and invasion properties were analyzed with miR-135b mimics or inhibitor-transfected cells and silenced expression of MTSS1 in miR-135b inhibitor transfected cells. CRC tissues showed significantly upregulated miR-135b expression and reduced MTSS1 expression. High miR-135b levels were significantly associated with lymph node and distant metastasis. The miR-135b inhibitor decreased miR-135b expression and caused MTSS1 upregulation at the post-transcriptional level. However, overexpression of miR-135b caused MTSS1 protein downregulation. The 3'-UTR of MTSS1 harbored a binding site for miR-135b. Finally, miR-135b inhibitor-transfected cells exhibited markedly reduced cell migration and invasive abilities, and this effect could be reversed by MTSS1-siRNA. Our results demonstrated that miR-135b downregulated MTSS1 expression and contributed to CRC cell invasion, indicating its involvement in CRC progression.
微小 RNA(miRNAs,miRs)在包括恶性肿瘤在内的人类疾病的发病机制和发展中发挥着重要作用。有些 miRNA 可能通过靶向肿瘤抑制基因来影响肿瘤的进展。miR-135b 在 CRC 中呈上调表达。在这项研究中,我们评估了 miR-135b 在结直肠癌(CRC)中的作用及其对转移抑制因子 1(MTSS1)的调控作用及其机制。采用 qRT-PCR 和 Western blot 分析检测 35 例 CRC 及相应癌旁组织、27 例结直肠腺瘤和 16 例正常组织样本中 miR-135b 和 MTSS1 基因的表达水平。通过转染 miR-135b 模拟物或抑制剂来下调 miR-135b 的表达,评估 miR-135b 对 MTSS1 表达的影响。通过 3'-UTR 双荧光素酶报告基因检测验证它们之间的直接相互作用。此外,通过转染 miR-135b 模拟物或抑制剂的细胞以及转染 miR-135b 抑制剂的细胞沉默 MTSS1 表达,分析 miR-135b 对调节 CRC 细胞迁移和侵袭特性的作用。CRC 组织显示出明显上调的 miR-135b 表达和下调的 MTSS1 表达。高水平的 miR-135b 与淋巴结和远处转移显著相关。miR-135b 抑制剂降低 miR-135b 的表达并导致 MTSS1 在转录后水平上的上调。然而,miR-135b 的过表达导致 MTSS1 蛋白下调。MTSS1 的 3'-UTR 含有 miR-135b 的结合位点。最后,miR-135b 抑制剂转染的细胞表现出明显降低的细胞迁移和侵袭能力,而这种效应可以通过 MTSS1-siRNA 逆转。我们的研究结果表明,miR-135b 下调 MTSS1 的表达并促进 CRC 细胞侵袭,表明其参与 CRC 的进展。